1-855-378-42281-855-378-4228
One of the out-patient treatment options for people in Montour struggling with opioid abuse and addiction is called opioid maintenance therapy. Some clinics and doctors are certified to administer certain medications to opioid addicted people, many of which are opioid-based themselves and are habit forming. In low enough amounts however, the individual does not experience being high but also doesn't have intense cravings and is not experiencing opioid withdrawal. Methadone is the first med administered for this sole purpose, but there are other choices to choose from.
Methadone is an opiate and can be taken at an out-patient medical center certified to administer the med, which is taken on a daily basis as a pill or liquid. The cost of the drug is approximately under $200 per month. Buprenorphine is also an opioid based drug, and is in pill form often taken one day on, one day off. But unlike Methadone that is only be administered in highly well-regulated medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The price monthly of buprenorphine is around three hundred dollars /month for the generic of the medication. There is also a type of buprenorphine that contains the ingredient naloxone, which is a drug that blocks the effects of opiates. An individual consuming this version of the drug, AKA Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and costs about $450 /month. Naltrexone is another med used in opioid maintenance therapy, but unlike the other drugs mentioned it is an opiate blocker and is not an opioid. A person has the choice to take this drug as a monthly shot, which is called Vivitrol. As an opioid blocker, it prevents an individual from experience high feelings from opioids, and in turn lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 per month.
For All Alcohol and Drug Rehab Centers In Montour, Click Here.
